|
See Melior at World Pharmaceutical Congress in Philadelphia, June 15-17
Melior Recieves Patent Notice for Repositioned Drug Candidate MLR-1023
Melior Announces Collaboration with Rhett Syndrome Research Trust
Repositioning Idle Drugs via Systematic Serendipity |
